COGT vs ORCL · $5.75B cap vs P/E 31, rev $67.36B
Cogent Biosciences Inc (COGT) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
Cogent Biosciences Inc (COGT) is a biotechnology company listed on NASDAQ.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Michael D. Sicilia.
COGT does not have a complete income-statement cache yet.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
COGT currently screens at market cap $5.75B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the COGT and ORCL stock pages for the full models.
Not investment advice.